March 26, 2025 09:24 PM EDT
Startups
Deals

Au­ri­on CEO is out as Al­con takes ma­jor­i­ty stake in cell ther­a­py start­up

Andrew Dunn

Senior Biopharma Correspondent

Eye gi­ant Al­con said Wednes­day it ac­quired a ma­jor­i­ty stake in cell ther­a­py start­up Au­ri­on and re­placed CEO Greg Kun­st, the lat­est twist in a …

Endpoints News

Sign up to read this article for free.

Get free access to a limited number of articles, plus choose newsletters to get straight to your inbox.

BECOME A PREMIUM SUBSCRIBER
TRENDING NOW

FDA's Pe­ter Marks re­signs, say­ing he won't ac­cept Kennedy's 'mis­in­for­ma­tion and lies'

Blue­bird gets new M&A bid, seek­ing to top pri­vate eq­ui­ty of­fer

BioN­Tech de­tails promis­ing mid-stage da­ta for its PD-L1xVEGF in ag­gres­sive lung can­cer

No­vo inks sec­ond obe­si­ty deal of the week, with Lex­i­con oral drug part­ner­ship worth up to $1B

‘Peo­ple will die’: End of NIH grants guts work be­tween aca­d­e­mics and com­pa­nies to counter next pan­dem­ic

FDA ap­proves Sanofi's RNAi drug for he­mo­phil­ia A and B

A service from the Financial Times